Status:
COMPLETED
Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Covid-19 Patients
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Resident cells of human adipose tissue express ACE2 and DPP4, receptors for SARS-Cov2. The hypothesis is that the virus may enter and spread in fat depots.
Eligibility Criteria
Inclusion
- Male or female ≥ 18 years old
- Patients testing positive for Covid19
- Patients affiliated to social security
- Signing of free and informed consent
Exclusion
- Vulnerable persons (- minors,
- adults under guardianship or curatorship,
- pregnant women,
- persons deprived of their liberty,
- persons who do not master the French language)
Key Trial Info
Start Date :
August 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 9 2020
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04427878
Start Date
August 3 2020
End Date
September 9 2020
Last Update
June 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06000